drugs: endocrine system

Republished: Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency
Natasha Daga, Flavian Joseph

Drug and Therapeutics Bulletin Sep 2021, 59 (9) 139-143; DOI: 10.1136/dtb.2021.234508rep
Republished: Severe hypophosphataemia following oral bisphosphonate treatment in a patient with osteoporosis
Louise Wulff Bagger, Per Kim Dyhr Hansen, Peter Schwarz, Barbara Rubek Nielsen

Drug and Therapeutics Bulletin Jul 2021, 59 (7) 107-111; DOI: 10.1136/dtb.2021.235083rep
Republished: Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis
Ross Leader, Jake Cowen, Surya Panicker Rajeev

Drug and Therapeutics Bulletin Apr 2020, 58 (4) 60-63; DOI: 10.1136/dtb.2019.231104rep
Republished: Metformin-associated lactic acidosis precipitated by liraglutide use: adverse effects of aggressive antihyperglycaemic therapy
Ananya Hooda, Anurag Mehta, Franck Hannallah

Drug and Therapeutics Bulletin Jul 2019, 57 (7) 109-111; DOI: 10.1136/dtb.2019.227102rep
Republished: DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
Simonette Padron, Everett Rogers, Michelle Demory Beckler, Marc Kesselman

Drug and Therapeutics Bulletin Jan 2020, 58 (1) 12-15; DOI: 10.1136/dtb.2019.228981rep
Republished: Partial nephrogenic diabetes insipidus associated with lithium therapy
Eka Nandoshvili, Steve Hyer, Nikhil Johri

Drug and Therapeutics Bulletin Mar 2020, 58 (3) 45-47; DOI: 10.1136/dtb.2019.231093rep

Main menu